Étienne Gagnon

9PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursNanomaterialsData structures and algorithmsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 20, 2025
MARC, a novel modular chimeric antigen receptor, improves T cell-based cancer immunotherapies by preventing early T cell exhaustion and enhancing persistence.

Margaux Tual, Angélique Bellemare-Pelletier, Susan Moore

|Jul 08, 2024
Long-term severe hypoxia adaptation induces non-canonical EMT and a novel Wilms Tumor 1 (WT1) isoform.

Jordan Quenneville, Albert Feghaly, Margaux Tual

|Dec 31, 2021
MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagy.

David Possamaï, Laïla-Aïcha Hanafi, Angélique Bellemare-Pelletier

|Oct 22, 2021
CAMAP: Artificial neural networks unveil the role of codon arrangement in modulating MHC-I peptides presentation.

Tariq Daouda, Maude Dumont-Lagacé, Albert Feghaly

|Jun 17, 2021
CD40L-Stimulated B Lymphocytes Are Polarized toward APC Functions after Exposure to IL-4 and IL-21.

David Possamaï, Gabriel Pagé, Rébecca Panès

|Mar 24, 2021
TMEM16F mediates bystander TCR-CD3 membrane dissociation at the immunological synapse and potentiates T cell activation.

Audrey Connolly, Rébecca Panes, Margaux Tual

Pageof 2

Frequent Collaborators

3 joint publications

Rébecca Panes

2 joint publications

Albert Feghaly

1 joint publications

Guillermo Arango Duque

1 joint publications

Mitsunori Fukuda